Cyanosis secondary prevention

Cyanosis Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cyanosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cyanosis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cyanosis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cyanosis secondary prevention
CDC on Cyanosis secondary prevention
Cyanosis secondary prevention in the news
Blogs on Cyanosis secondary prevention
Directions to Hospitals Treating Cyanosis
Risk calculators and risk factors for Cyanosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Secondary prevention in cyanotic congenital heart disease includes obtaining EKG Exercise stress test, Holter monitoring, Transthoracic echocardiography, Cardiac MRI, Cardiac CT Scan, Pulse oximetry every 12-60 months based on the stage of disease.

Secondary Prevention

• Secondary prevention in cyanotic congenital heart disease includes obtaining EKG Exercise stress test, Holter monitoring, Transthoracic echocardiography, Cardiac MRI, Cardiac CT Scan, Pulse oximetry every 12-60 months based on the stage of disease.